Kalbitor

Active Ingredient(s): Ecallantide
FDA Approved: * November 27, 2009
Pharm Company: * DYAX CORP.

Ecallantide (trade name Kalbitor) is a drug used for the treatment of hereditary angioedema (HAE) and in the prevention of blood loss in cardiothoracic surgery.[1] It is an inhibitor of the protein kallikrein and a 60-amino acid polypeptide which was developed from a Kunitz domain through phage display to mimic antibodies inhibiting kallikrein.[1] Contents 1 Medical uses 1.1 Angioedema 2 Adverse effects 3 Interactions 4 Mechanism of action 5 See also 6 Ref... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Kalbitor 10 mg/ml Subcutaneous Injection, Solution

NDC: 47783-101

Labeler:

Dyax Corp.

Kalbitor 10 mg/ml Subcutaneous Injection, Solution

NDC: 65044-7611

Labeler:

Jubilant Hollisterstier LLC